Delivery Order SPE2DB22D2206-SPE2DB25FJD80
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Propranolol ER 160 mg capsules in quantities of 100 units, with a contract ceiling value of $7,012.89. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $10,415.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, with performance to be completed by August 14, 2025, at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $1,469.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Propranolol ER 160 mg capsules (100-count units). The contract is non-set-aside and represents a competitively awarded delivery order with an ultimate completion date of July 24, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,209.06 firm fixed-price delivery order is for the supply of 100 units of 120 mg Propranolol ER capsules. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,935.69 firm fixed-price delivery order is for the supply of 4,567,021,550 units of the medication Propranolol ER 80 mg capsules. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.82 firm fixed-price delivery order is for the supply of 100 capsules of Propranolol ER 80 mg, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,229.72 firm-fixed-price contract is for the delivery of 100 counts of 60 mg Propranolol ER capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for DLA Troop Support Medical through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,254,976 units of the generic medication Propranolol ER 80 mg capsules. The $2,378.19 firm fixed-price contract has a completion date of December 5, 2022, and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,392,715 units of Propranolol ER 120 mg capsules in 100-count bottles. The contract has a total ceiling value of $7,150.54 and was awarded on August 8, 2024, with an ultimate completion date of August 9, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,337.51, is for the delivery of 100 units of Propranolol ER 80 mg capsules. It is a firm-fixed-price delivery order contract with a completion date of February 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD80Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) with a contract value of $6,630.72 and an ultimate completion date of July 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026. The place of performance is located in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order for propranolol, a beta-blocker commonly used for cardiovascular and hypertension management, exemplifies the company's role in supplying essential pharmaceutical products across multiple therapeutic domains to support federal medical procurement needs. The contract reflects the company's established capability to meet competitive federal procurement requirements and deliver specialized medical commodities through flexible contract vehicles designed to support global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/30/25 |